[ASAP] Lutetium177-Labeled DOTA-Ibandronate: A Novel Radiopharmaceutical for Targeted Treatment of Bone Metastases

Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.2c00978

Source: Molecular Pharmaceutics - February 20, 2023 Category: Drugs & Pharmacology Authors: Qixin Wang, Jian Yang, Yingwei Wang, Hanxiang Liu, Yue Feng, Lin Qiu, and Yue Chen Source Type: research